Elga Lohler - Smith Nephew Chief Human Resource Officer

SNNUF Stock  USD 14.60  0.60  4.29%   

Executive

Ms. Elga Lohler is Chief Human Resource Officer of the Company. She joined Smith Nephew in January 2002 as Director of HR and has since held progressively senior positions in Wound Management, Operations, Corporationrationrate Functions and Group. Elga became Chief Human Resources Officer in December 2015 and leads the Global Human Resources, Internal Communication and Sustainability Functions. Elga is based in Fort Worth, US. Skills and Experience Elga has more than 25 years Human Resources experience. Prior to joining Smith Nephew, Elga held Human Resources roles at Transnet, Sensormatic and Advanced Tissue Sciences, which was acquired by Smith Nephew in 2002. Through these roles, Elga has developed deep expertise in strategy planning and development, organisational design and effectiveness, restructuring and integration and transformational change in support of business objectives. In her current roles, Elga is responsible for driving Smith Nephews human capital strategy across the enterprise in support of the company overall business plan and strategic direction. Elga holds an undergraduate degree in Psychology and a Masters degree in Organizational Psychology, both from the University of Witwatersrand in South Africa. since 2015.
Age 55
Tenure 10 years
Phone44 1923 477 100
Webhttps://www.smith-nephew.com

Smith Nephew Management Efficiency

The company has return on total asset (ROA) of 0.0425 % which means that it generated a profit of $0.0425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0925 %, meaning that it generated $0.0925 on every $100 dollars invested by stockholders. Smith Nephew's management efficiency ratios could be used to measure how well Smith Nephew manages its routine affairs as well as how well it operates its assets and liabilities.
Smith Nephew plc has accumulated 2.71 B in total debt with debt to equity ratio (D/E) of 0.54, which is about average as compared to similar companies. Smith Nephew plc has a current ratio of 1.74, which is within standard range for the sector. Debt can assist Smith Nephew until it has trouble settling it off, either with new capital or with free cash flow. So, Smith Nephew's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Smith Nephew plc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Smith to invest in growth at high rates of return. When we think about Smith Nephew's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Michael DonovanAxogen Inc
59
Natalia KozminaLivaNova PLC
N/A
Michael ParksLucid Diagnostics
N/A
Craig SwandalAxogen Inc
64
Matthew IIILivaNova PLC
N/A
Yuliya AslanParagon 28
N/A
Kimberly LockwoodCONMED
N/A
Todd PuckettAxogen Inc
N/A
Jeff SearsParagon 28
N/A
Hans KestlerParagon 28
N/A
Lisa WolfTivic Health Systems
62
Victoria MDLucid Diagnostics
N/A
Harold MBAAxogen Inc
N/A
Stephen DeitschParagon 28
52
Robert JDParagon 28
58
Trui HebbelinckLivaNova PLC
52
Kenneth WashingtonMedtronic PLC
65
Deanna WilkeLivaNova PLC
N/A
Daniel EsqCONMED
60
Jonathan FriedmanParagon 28
53
Mark KarshnerOrthopediatrics Corp
N/A
Smith Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. Smith Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom. Smith Nephew operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 18000 people. Smith Nephew plc [SNNUF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Smith Nephew plc Leadership Team

Elected by the shareholders, the Smith Nephew's board of directors comprises two types of representatives: Smith Nephew inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Smith. The board's role is to monitor Smith Nephew's management team and ensure that shareholders' interests are well served. Smith Nephew's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Smith Nephew's outside directors are responsible for providing unbiased perspectives on the board's policies.
Alison Parkes, Chief Officer
Paul Connolly, Pres Operations
Deepak Nath, CEO Director
Joe Metzger, VP Communications
Andrew Swift, VP Relations
AnneFrancoise Nesmes, CFO Director
Helen Barraclough, Company Counsel
Elga Lohler, Chief Human Resource Officer
Bradley Cannon, Sports Orthopaedics
Philip Cowdy, Chief Officer

Smith Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Smith Nephew a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Smith Pink Sheet

Smith Nephew financial ratios help investors to determine whether Smith Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Smith with respect to the benefits of owning Smith Nephew security.